BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 12843318)

  • 1. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain.
    Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Schanen C; Tamura M
    J Med Genet; 2003 Jul; 40(7):487-93. PubMed ID: 12843318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems.
    Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Dragich J; Schanen C; Tamura M
    Brain Dev; 2001 Dec; 23 Suppl 1():S165-73. PubMed ID: 11738866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
    Buschdorf JP; Strätling WH
    J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA.
    Ballestar E; Yusufzai TM; Wolffe AP
    Biochemistry; 2000 Jun; 39(24):7100-6. PubMed ID: 10852707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MeCP2 and other methyl-CpG binding proteins.
    Jørgensen HF; Bird A
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):87-93. PubMed ID: 12112733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome.
    Amano K; Nomura Y; Segawa M; Yamakawa K
    J Hum Genet; 2000; 45(4):231-6. PubMed ID: 10944854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional significance of MeCP2 mutations in patients with Rett syndrome].
    Kudo S
    No To Hattatsu; 2002 May; 34(3):224-9. PubMed ID: 12030011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome.
    Nan X; Bird A
    Brain Dev; 2001 Dec; 23 Suppl 1():S32-7. PubMed ID: 11738839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences of Rett syndrome mutations on human MeCP2.
    Yusufzai TM; Wolffe AP
    Nucleic Acids Res; 2000 Nov; 28(21):4172-9. PubMed ID: 11058114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots.
    Wan M; Lee SS; Zhang X; Houwink-Manville I; Song HR; Amir RE; Budden S; Naidu S; Pereira JL; Lo IF; Zoghbi HY; Schanen NC; Francke U
    Am J Hum Genet; 1999 Dec; 65(6):1520-9. PubMed ID: 10577905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation specifies chromosomal localization of MeCP2.
    Nan X; Tate P; Li E; Bird A
    Mol Cell Biol; 1996 Jan; 16(1):414-21. PubMed ID: 8524323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2).
    Moog U; Smeets EE; van Roozendaal KE; Schoenmakers S; Herbergs J; Schoonbrood-Lenssen AM; Schrander-Stumpel CT
    Eur J Paediatr Neurol; 2003; 7(1):5-12. PubMed ID: 12615169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.
    LaSalle JM; Goldstine J; Balmer D; Greco CM
    Hum Mol Genet; 2001 Aug; 10(17):1729-40. PubMed ID: 11532982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.
    Amir RE; Zoghbi HY
    Am J Med Genet; 2000; 97(2):147-52. PubMed ID: 11180222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
    Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.
    Ballestar E; Ropero S; Alaminos M; Armstrong J; Setien F; Agrelo R; Fraga MF; Herranz M; Avila S; Pineda M; Monros E; Esteller M
    Hum Genet; 2005 Jan; 116(1-2):91-104. PubMed ID: 15549394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl-CpG binding proteins in the nervous system.
    Fan G; Hutnick L
    Cell Res; 2005 Apr; 15(4):255-61. PubMed ID: 15857580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rett syndrome: a surprising result of mutation in MECP2.
    Dragich J; Houwink-Manville I; Schanen C
    Hum Mol Genet; 2000 Oct; 9(16):2365-75. PubMed ID: 11005791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation in the gene body influences MeCP2-mediated gene repression.
    Kinde B; Wu DY; Greenberg ME; Gabel HW
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of MECP2 gene mutation and X-chromosome inactivation on the Rett syndrome phenotype.
    Chae JH; Hwang H; Hwang YS; Cheong HJ; Kim KJ
    J Child Neurol; 2004 Jul; 19(7):503-8. PubMed ID: 15526954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.